5 years ago

Cyclopropenones for Metabolic Targeting and Sequential Bioorthogonal Labeling

Cyclopropenones for Metabolic Targeting and Sequential Bioorthogonal Labeling
R. David Row, Jennifer A. Prescher, Ryan A. Mehl, Austin T. Alexander, Hui-Wen Shih
Cyclopropenones are attractive motifs for bioorthogonal chemistry, owing to their small size and unique modes of reactivity. Unfortunately, the fastest-reacting cyclopropenones are insufficiently stable for routine intracellular use. Here we report cyclopropenones with improved stability that maintain robust reactivity with bioorthogonal phosphines. Functionalized cyclopropenones were synthesized and their lifetimes in aqueous media and cellular environments were analyzed. The most robust cyclopropenones were further treated with a panel of phosphine probes, and reaction rates were measured. Two of the phosphine scaffolds afforded ∼100-fold rate enhancements compared to previously reported reagents. Importantly, the stabilized cyclopropenones were suitable for recombinant protein production via genetic code expansion. The products of the cyclopropenone ligation were also amenable to traceless Staudinger ligations, setting the stage for tandem labeling experiments.

Publisher URL: http://dx.doi.org/10.1021/jacs.7b03010

DOI: 10.1021/jacs.7b03010

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.